Marcus Banks

3 days ago | medscape.com | Marcus Banks

LAS VEGAS — Since its approval by the US Food and Drug Administration in 2015, transurethral water-vapor therapy has been gaining traction as an in-office procedure for reducing the symptoms of benign prostatic hyperplasia. But how long the benefits of the treatment, marketed as Rezūm by Boston Scientific, last is less clear. That part of the picture is coming into focus, thanks to a collection of posters about the approach at American Urological Association (AUA) 2025 Annual Meeting.

Feb 3, 2025 | espanol.medscape.com | Marcus Banks

Las nuevas recomendaciones de la American Society of Regional and Anesthesia Pain Medicine (ASRA) ofrecen estrategias para que los anestesiólogos y médicos especialistas en el tratamiento del dolor prevengan las infecciones que se desarrollan después de cirugías y otros procedimientos para el control del dolor.[1] Las infecciones del sitio quirúrgico, que se estima ocurren 500.000 veces tan solo en Estados Unidos, aumentan los costos hospitalarios en más de 20.000 dólares por ingreso y...

Dec 5, 2024 | specialtypharmacycontinuum.com | Marcus Banks

By Marcus A. BanksThe Risk Evaluation and Mitigation Strategy (REMS) that specialty pharmacists employ for certain high-risk medications can be cumbersome and time-intensive, with manual entry requirements plus a lengthy process involving numerous stakeholders to prove that a drug will do more benefit than harm for a given patient, speakers noted at the NASP 2024 Annual Meeting & Expo, in Nashville, Tenn.

Dec 5, 2024 | pharmacypracticenews.com | Marcus Banks

Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksThe Risk Evaluation and Mitigation Strategy (REMS) that specialty pharmacists employ for certain high-risk medications can be cumbersome and time-intensive, with manual entry requirements plus a lengthy process involving numerous stakeholders to prove that a drug will do more benefit than harm for a given patient, speakers noted at the NASP 2024 Annual Meeting & Expo, in Nashville, Tenn.

Mar 12, 2024 | medscape.com | Marcus Banks

Rates of maternal mortality in the United States are lower than previous estimates, according to a study published today in the American Journal of Obstetrics & Gynecology on March 13, 2024. Researchers said inaccurate recordkeeping has created undue alarm that the number of women who die while pregnant or soon after giving birth is rising. The maternal mortality rate is stable, they report, and deaths due to obstetric complications have dropped.